TY - JOUR
T1 - Interventions to address chronic disease and HIV
T2 - Strategies to promote smoking cessation among HIV-infected individuals
AU - Niaura, Raymond
AU - Chander, Geetanjali
AU - Hutton, Heidi
AU - Stanton, Cassandra
PY - 2012/12
Y1 - 2012/12
N2 - Tobacco use, especially cigarette smoking, is higher than average in persons living with HIV/AIDS (PLWHA). The Public Health Service Clinical Practice Guideline for Treating Tobacco Use and Dependence states that, during every medical encounter, all smokers should be offered smoking cessation counseling, along with approved medications. The Guideline also recognizes PLWHA as a priority population, given the scarcity of research on effective cessation treatments in this group. The scant evidence suggests that conventional treatments, though worthwhile, are not as successful as might be hoped for. The reasons for this are not entirely clear, butmay have to do with the complex array of medical and psychosocial factors that complicate their lives. Clinicians should consider re-treatment strategies for those patients who encounter difficulty when quitting smoking with conventional approaches, switching or augmenting treatments as needed to minimize adverseexperiences, and to maximize tolerability, adherence, and cessation outcomes.
AB - Tobacco use, especially cigarette smoking, is higher than average in persons living with HIV/AIDS (PLWHA). The Public Health Service Clinical Practice Guideline for Treating Tobacco Use and Dependence states that, during every medical encounter, all smokers should be offered smoking cessation counseling, along with approved medications. The Guideline also recognizes PLWHA as a priority population, given the scarcity of research on effective cessation treatments in this group. The scant evidence suggests that conventional treatments, though worthwhile, are not as successful as might be hoped for. The reasons for this are not entirely clear, butmay have to do with the complex array of medical and psychosocial factors that complicate their lives. Clinicians should consider re-treatment strategies for those patients who encounter difficulty when quitting smoking with conventional approaches, switching or augmenting treatments as needed to minimize adverseexperiences, and to maximize tolerability, adherence, and cessation outcomes.
KW - Adaptive treatment strategy
KW - Behavioral aspects of HIV/AIDS
KW - Bupropion
KW - Cigarette smoking
KW - HIV/AIDS
KW - People living with HIV/AIDS (PLWHA)
KW - Smoking cessation
KW - Tobacco
KW - Treatment
KW - Varenicline
UR - http://www.scopus.com/inward/record.url?scp=84872181937&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84872181937&partnerID=8YFLogxK
U2 - 10.1007/s11904-012-0138-4
DO - 10.1007/s11904-012-0138-4
M3 - Article
C2 - 22972495
AN - SCOPUS:84872181937
SN - 1548-3568
VL - 9
SP - 375
EP - 384
JO - Current HIV/AIDS Reports
JF - Current HIV/AIDS Reports
IS - 4
ER -